Developers of animal health products have to factor in multiple variables when sourcing manufacturing solutions. They need to maintain regulatory compliance and ensure scalability, while also enabling product innovation.
Meeting the requirements of regulatory agencies such as the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) demands strict adherence to Good Manufacturing Practices, including consistent production processes and robust quality control.
As the world’s only CRO/CDMO dedicated to animal health products, our global teams have extensive expertise in animal drug manufacturing, offering advice and capabilities around delivery systems, formulation, and packaging. Working closely with you, our strategic guidance can enhance the manufacturing process for your animal health products.
Our four global manufacturing sites are EMA- and FDA-approved, as well as GMP-compliant. We currently produce over 125 different commercial animal health products across these sites and are continuously innovating to develop new product types, formulations, and manufacturing processes.
Our size, flexibility, and expertise enable us to scale manufacturing for our customers' animal health products, empowering them to focus instead on creating awareness, demand, and growth for their new solutions via marketing and distribution.
Our four EMA- and FDA-approved, GMP-compliant sites can support your product at every stage—from formulation and delivery systems to packaging—ensuring quality, scalability, and efficiency.
Whether you need support for sterile or non-sterile product manufacturing, we can deliver solutions tailored to your requirements.
From ‘molecule to market’, Argenta offers a comprehensive package of services to support your commercialisation goals. Wherever you are in your product development journey, we can help.
